arrow
A

Amro Taha

West Virginia University
H指数:5
被引数:53

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative Effectiveness of Amiodarone Versus Lidocaine as Antiarrhythmic Therapy for Cardiac Arrest with Shockable Rhythms: A Systematic Review and Meta-Analysis

胺碘酮与利多卡因作为可电击心律的心脏骤停抗心律失常疗法的比较效果:一项系统评价和Meta分析

2026-09-190
OA
Correlation of Echocardiographic Right Ventricular Functional Parameters with CMR-Derived Right Ventricular Ejection Fraction in Pulmonary Hypertension: A Systematic Review and Meta-Analysis

肺动脉高压患者中超声心动图右心室功能参数与CMR衍生的右心室射血分数的相关性:一项系统评价和Meta分析

2026-09-090
OA
Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses

比较阿哌沙班与利伐沙班在急性静脉血栓栓塞症中的安全性和有效性:一项倾向性匹配的真实世界TriNetX研究,包括肥胖和癌症亚组分析

2026-07-110
OA
GLP-1 Receptor Agonists or Dual GLP-1/GIP Receptor Agonists vs. SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis

胰高血糖素样肽-1受体激动剂或双重GLP-1/GIP受体激动剂与SGLT2抑制剂在心房颤动和HFpEF患者中的比较:一项倾向性匹配的真实世界分析

2026-06-270
OA
Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis

GLP-1受体激动剂和SGLT2抑制剂联合疗法在心力衰竭中的临床结局:一项真实世界倾向性匹配TriNetX分析

2026-06-170
OA
Cardiovascular Outcomes with Colchicine in Coronary Artery Disease and HFpEF: A Propensity-Matched TriNetX Analysis

在冠状动脉疾病和HFpEF中应用秋水仙碱的心血管结局:一项TriNetX倾向性匹配分析

2026-05-010
PRE